| An intra-tumoral niche maintains and differentiates stem-like CD8 T cells CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ... Nature 576 (7787), 465-470, 2019 | 595 | 2019 |
| Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica CA Gilchrist, SE Petri, BN Schneider, DJ Reichman, N Jiang, S Begum, ... The Journal of infectious diseases 213 (10), 1579-1585, 2016 | 121 | 2016 |
| CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, ... Immunity 56 (1), 107-124. e5, 2023 | 102 | 2023 |
| The requirement for immune infiltration and organization in the tumor microenvironment for successful immunotherapy in prostate cancer CS Jansen, N Prokhnevska, HT Kissick Urologic Oncology: Seminars and Original Investigations 37 (8), 543-555, 2019 | 25 | 2019 |
| A subset of localized prostate cancer displays an immunogenic phenotype associated with losses of key tumor suppressor genes C Calagua, M Ficial, CS Jansen, T Hirz, L Del Balzo, S Wilkinson, R Lake, ... Clinical Cancer Research 27 (17), 4836-4847, 2021 | 24 | 2021 |
| Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood JW Carlisle, CS Jansen, MA Cardenas, E Sobierajska, AM Reyes, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 20 | 2022 |
| The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients C Margaroli, MA Cardenas, CS Jansen, A Moon Reyes, F Hosseinzadeh, ... OncoImmunology 9 (1), 1747731, 2020 | 11 | 2020 |
| Neoadjuvant cabozantinib in an unresectable locally advanced renal cell carcinoma patient leads to downsizing of tumor enabling surgical resection: a case report MA Bilen, JF Jiang, CS Jansen, JT Brown, LR Harik, A Sekhar, H Kissick, ... Frontiers in Oncology 10, 622134, 2021 | 7 | 2021 |
| Tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response HK Nataliya Prokhnevska, Maria Cardenas, Caroline Jansen, Rajesh ... The Journal of Immunology 204 (1 Supplement), 165.5-165.5, 2020 | 2 | 2020 |
| How tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response N Prokhnevska, R Valanparambil, C Jansen, V Master, M Sanda, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 2 | 2019 |
| Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis JS Patel, Y Woo, A Draper, CS Jansen, JW Carlisle, PF Innominato, ... Journal for Immunotherapy of Cancer 12 (3), 2024 | 1 | 2024 |
| Physician–scientist trainees with parenting responsibilities need financial and childcare support CS Jansen, A Sugiura, L Stalbow, C Nguyen, JP Lever, A Peiper, ... Nature medicine 29 (12), 2990-2992, 2023 | 1 | 2023 |
| Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS CS Jansen, RS Prabhu, MS Pagadala, P Chappa, S Goyal, C Zhou, ... Research Square, 2023 | 1 | 2023 |
| CD8 T cell activation in cancer is comprised of two distinct phases N Prokhnevska, MA Cardenas, R Valanparambil, E Sobierajska, ... The Journal of Immunology 208 (1_Supplement), 121.09-121.09, 2022 | 1 | 2022 |
| CD8 T cell differentiation in cancer is comprised of two distinct phases N Prokhnevska, M Cardenas, R Valanparambil, C Jansen, V Master, ... The Journal of Immunology 206 (1_Supplement), 57.04-57.04, 2021 | 1 | 2021 |
| Pandemic pause: Lessons in unscrambling my daily life CS Jansen Academic Medicine 95 (12), 1899, 2020 | 1 | 2020 |
| Understanding and overcoming resistance to immunotherapy in genitourinary cancers ST Evans, Y Jani, CS Jansen, A Yildirim, E Kalemoglu, MA Bilen Cancer Biology & Therapy 25 (1), 2342599, 2024 | | 2024 |
| Established and emerging biomarkers of immunotherapy in renal cell carcinoma Y Jani, CS Jansen, MB Gerke, MA Bilen Immunotherapy, 2024 | | 2024 |
| Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition S Wilkinson, AT Ku, RT Lis, IM King, D Low, SY Trostel, JR Bright, ... medRxiv, 2024.02. 09.24302395, 2024 | | 2024 |
| Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma CS Jansen, Y Choi, ST Evans, R Greenwald, JA Behnke, C Hartman, ... Frontiers in Oncology 13, 1271255, 2023 | | 2023 |
Haydn KissickEmory UniversityVerified email at emory.edu
